Preparation and in vitro characterization of gelatin microspheres containing 5-fluorouracil

Journal of Macromolecular Science, Part B: Physics

Volumn 51, Issue 6, 2012, Pages 1117-1124

  Peng, Zhiyuan ^a   Li, Zhiping ^a   Shen, Yongqiang ^a  

^a JISHOU UNIVERSITY   (China)

Author keywords

5 fluorouracil; characterization; gelatin microspheres; preparation

Indexed keywords

5-FLUOROURACIL; 5-FLUOROURACIL (5-FU); AQUEOUS MEDIA; CHEMICAL CROSS-LINKING; CROSS LINKING AGENTS; DRUG RELEASE; GELATIN MICROSPHERES; GLUTARALDEHYDES; IN-VITRO; PREPARATION; RELEASE PROFILES; RELEASE RATE; SWELLING PROPERTIES; SWELLING RATIO;

ALDEHYDES; CHARACTERIZATION; CROSSLINKING; EMULSIFICATION;

MICROSPHERES;

EID: 84862545648     PISSN: 00222348     EISSN: 1525609X     Source Type: Journal    
DOI: 10.1080/00222348.2011.625901     Document Type: Article

References (16)

1. Wan, L.S.; Heng, P.W.; Chan, L.W. Drug encapsulation in alginate microspheres by emulsification. J. Microencap. 1992, 9, 309.
2. Dinarvand, R.; Mahmoodi, S.; Farboud, E. Effect of process variables on particle size of gelatin microspheres containing lactic acid. Pharm. Dev. Tech. 2004, 9, 291.
3. Tabata, Y.; Uno, K.; Ikada, Y.; Muramatsus, S. Synthesis of gelatin microspheres containing interferon. Pharm. Res. 1989, 6, 422.
4. Jalon, E.; Blanco-Prieto, M.J.; Ygartua, P.; Santoyo, S. PLGA microparticles: Possible vehicles for topical drug delivery. Int. J. Pharm. 2001, 226, 181.
5. Freiberg, S.; Zhu, X.X. Polymer microspheres for controlled drug release. Int. J. Pharm. 2004, 282, 1.
6. Fan, H.; Dash, A.K. Effect of cross-linking on the in vitro release kinetics of doxorubicin from gelatin implants. Int. J. Pharm. 2001, 213, 103.
7. Vandelli, M.A.; Rivasi, F.; Guerra, P.; Forni, F.; Arletti, R. Gelatin microspheres cross-linked with D,L-glyceraldehyde as a potential drug delivery system: Preparation, characterization, in vitro and in vivo studies. Int. J. Pharm. 2001, 215, 175.
8. Brime, B.; Ballesteros, M.P.; Frutos, P. Preparation and in vitro characterization of gelatin microspheres containing Levodopa for nasal administration. J. Microencap. 2000, 17, 777.
9. Digenis, G.A.; Thomas, B.G.; Shah, V.P. Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance. J. Pharm. Sci. 1994, 83, 915.
10. Liang, H.C.; Chang, W.H.; Lin, K.J. Genipin-crosslinked gelatin microspheres as a drug carrier for intramuscular administration: In vitro and in vivo studies. J. Biomed. Mater. Res. A 2003, 65, 271.
11. Ugwoke, M.I.; Kinget, R. Influence of processing variables on the properties of gelatin microspheres prepared by the emulsification solvent extraction technique. J. Microencapsul. 1998, 15, 273.
12. Sun, R.; Shi, J.; Guo, Y.; Chen, L. Studies on the particle size control of gelatin microspheres. Front. Chem. China 2009, 4, 222.
13. Li, H.S.; Wei, S.L.; Lu, W. Studies on gelatin microspheres-in-oil emulsion of pingyangmycin. Acta Pharmacol. Sin. 1995, 30, 390.
14. Vandelli, M.A.; Rivasi, F.; Guerra, P.; Forni, F.; Arletti, R. Gelatin microspheres crosslinked with D, L-glyceraldehyde as a potential drug delivery system: Preparation, characterisation, in vitro and in vivo studies. Int. J. Pharm. 2001, 215, 175.
15. Muvaffak, A.; Gurhan, I.; Hasirci, N. Cytotoxicity of 5-fluorouracil entrapped in gelatin microspheres. J. Microencapsul. 2004, 21, 293.
16. Peng, Z.Y.; Li, Z.P.; Shen, Y.Q. Control of size and morphology of gelatin microspheres. J. Macromol. Sci. B, Phys. 2012, 51, 12.